Sapir Alex

CIK 00017094153 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001709415

Recent Transactions

16 trades

Award
Fulcrum Therapeutics, Inc.$FULC
Stock option - Right to Buy
2026-02-02+650,000→ 650,000 total
Award
Fulcrum Therapeutics, Inc.$FULC
Stock option - Right to Buy
2025-01-24+582,000→ 582,000 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Stock option - Right to Buy
2024-07-03−150,000→ 2,280,400 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2024-07-03$3.27/sh+150,000→ 193,360 total
Purchase
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2024-03-04$11.35/sh+43,360→ 43,360 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Restricted Stock Units
2023-05-19−3,750→ 0 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2023-05-19+3,750→ 3,750 total
Award
PhaseBio Pharmaceuticals Inc
Non-employee Director Stock Option (right to buy)
2022-05-19+17,500→ 17,500 total
Award
PhaseBio Pharmaceuticals Inc
Restricted Stock Units
2022-05-19+3,750→ 3,750 total
Award
PhaseBio Pharmaceuticals Inc
Non-employee Director Stock Option (right to buy)
2021-06-03+14,000→ 14,000 total
Award
PhaseBio Pharmaceuticals Inc
Non-employee Director Stock Option (right to buy)
2020-06-03+4,909→ 4,909 total
Award
PhaseBio Pharmaceuticals Inc
Employee Stock Option (right to buy)
2020-02-12+32,000→ 32,000 total
Purchase
Dova Pharmaceuticals Inc.
Common Stock
2018-08-14$22.83/sh+21,700→ 21,700 total
Exercise/Conversion
Dova Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
2017-12-22−26,809→ 887,291 total
Exercise/Conversion
Dova Pharmaceuticals Inc.
Common Stock
2017-12-22$3.73/sh+26,809→ 46,909 total
Purchase
Dova Pharmaceuticals Inc.
Common Stock
2017-07-05$17.00/sh+20,100→ 20,100 total

Companies

Recent Filings

Address

C/O FULCRUM THERAPEUTICS, INC. 26 LANDSDOWNE STREET

CAMBRIDGE, MA, 02139

View on SEC.gov